{
    "nctId": "NCT00600275",
    "briefTitle": "A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer",
    "officialTitle": "A Phase I/II, Multi-center, Open-label Study of BGT226, Administered Orally in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Solid Tumors, Breast Cancer, Cowden Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 57,
    "primaryOutcomeMeasure": "Maximum Tolerated Dose (MTD) of BGT226 (Phase I dose escalation) Safety and tolerability of BGT226 (all patients) Clinical tumor response in patients with advanced breast cancer (Phase II)",
    "eligibilityCriteria": "Inclusion criteria:\n\nAll patients\n\n* Histologically-confirmed, advanced solid tumors\n* Progressive, recurrent unresectable disease\n\nPhase II expansion part (advanced breast cancer)\n\n* Confirmed positive hormone receptor (estrogen receptor and/or progesterone receptor) or positive HER-2 expression status\n* Disease progression/recurrence following hormonal or anti-HER-2 treatment for advanced disease\n* At least one but not more than two prior chemotherapy regimens for the unresectable tumor\n* Measurable disease by MRI or CT scan\n\nCowden Syndrome patients with an advanced malignancy Genetic confirmation of Cowden Syndrome\n\n* Age \u2265 18\n* World Health Organization (WHO) Performance Status of \u2264 2\n\nExclusion criteria:\n\n* Hematopoietic:\n* No diabetes mellitus or history of gestational diabetes mellitus\n* No acute or chronic renal disease\n* No acute or chronic liver disease\n* No acute or chronic pancreatitis\n* No impaired cardiac function or clinically significant cardiac diseases such as ventricular arrhythmia, congestive heart failure, uncontrolled hypertension\n* No acute myocardial infarction or unstable angina pectoris within the past 3 months\n* Not pregnant or nursing and fertile patients must use barrier contraceptives\n\nOther protocol-defined inclusion/exclusion criteria may apply.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}